CSF2 and neoplasm: CXC chemokine ligand 2 recruits neutrophils to the tumor site, and the elevated expression of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor (TNF) around the tumor modulates neutrophils into an immunosuppressive state, thereby inhibiting the immunity of T cells.